Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Q1 2021 Earnings Conference Call May 6, 2021 8:30 AM ET Company Participants Meredith Kaya - VP, IR & Corporate Communications Thomas McCourt - President & Interim CEO Gina Consylman - Principal Accounting Officer, CFO, SVP & Treasurer Michael Shetzline - Chief Medical Officer, SVP & Head, Drug Development Conference Call Participants Jacob Hughes - Wells Fargo Securities Hannah Adeoye - JPMorgan Chase & Co. David Lebowitz - Morgan Stanley Operator Good day, and ...